Bayer ROE 2024

Bayer ROE

-0.09

Bayer Dividend yield

Ticker

BAYN.DE

ISIN

DE000BAY0017

WKN

BAY001

In 2024, Bayer's return on equity (ROE) was -0.09, a -183.45% increase from the 0.11 ROE in the previous year.

Bayer Aktienanalyse

What does Bayer do?

Bayer AG is a German company that was founded in 1863 by Friedrich Bayer and Johann Friedrich Weskott in Wuppertal. The company started out as a manufacturer of dyes, but over time it has evolved into a leading global agrochemical, health, and life science company. Bayer's business model is based on the goal of finding innovative solutions to the societal challenges of the future. This includes promoting agriculture and health, as well as sustainability and the preservation of natural resources. Bayer specializes in three business areas: Pharmaceuticals, Consumer Health, and Crop Science. In the Pharmaceuticals division, Bayer develops and markets innovative drugs for a variety of diseases. The company focuses on research and development in key therapy areas such as cardiology, oncology, hematology, neurology, and immunology. Well-known and successful brands from Bayer in the Pharmaceuticals sector include Xarelto, Kogenate, Stivarga, Eylea, and Nexavar. In the Consumer Health division, Bayer develops and distributes products for consumer health and well-being. This includes self-medication products, dietary supplements, contact lens care products, and animal health products. Well-known brands from Bayer Consumer Health include Aspirin, Bepanthen, Berocca, Coppertone, and Advantage. In the Crop Science division, Bayer develops and markets products and solutions for agriculture. This includes crop protection products, seeds, plant breeding, and digital farming. The goal is to help farmers worldwide operate sustainably and productively to meet the growing demand for food. Well-known brands from Bayer Crop Science include Roundup, Decis, Diflubenzuron, and Dekalb. Bayer is known for its innovative power and has made many inventions and discoveries throughout its history. It was one of the first companies to develop synthetic dyes, and in 1897, it was also the first company in Germany to manufacture Aspirin. Since then, Bayer has made numerous groundbreaking discoveries and is now at the forefront of the pharmaceutical and agrochemical industry. Bayer is headquartered in Leverkusen and operates in over 90 countries worldwide. The company employs over 100,000 people and had a turnover of around 41 billion euros in 2020. The company is also committed to reducing its ecological footprint in line with its business goals and strives to improve sustainability in its value chain. Bayer ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Bayer revenue by segment

In the annual report of the Bayer share (DE000BAY0017, BAY001, BAYN.DE), it breaks down its revenues into 4 segments: 1. Pharmaceuticals, 2. Consumer Health, 3. All Other Segments, 4. Crop Science. The Bayer stock (WKN: BAY001, ISIN: DE000BAY0017, Ticker Symbol: BAYN.DE) is a leading investment for investors interested in participating in the Health Care sector.

ROE Details

Decoding Bayer's Return on Equity (ROE)

Bayer's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Bayer's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Bayer's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Bayer’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Bayer Stock

What is the ROE (Return on Equity) of Bayer this year?

The ROE of Bayer this year is -0.09 undefined.

How has the Return on Equity (ROE) of Bayer developed compared to the previous year?

The ROE of Bayer has increased by -183.45% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Bayer?

A high ROE indicates that Bayer generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Bayer?

A low ROE can indicate that Bayer is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Bayer affect the company?

A change in ROE (Return on Equity) of Bayer can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Bayer?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Bayer?

Some factors that can influence Bayer's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Bayer pay?

Over the past 12 months, Bayer paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Bayer is expected to pay a dividend of 2.43 EUR.

What is the dividend yield of Bayer?

The current dividend yield of Bayer is .

When does Bayer pay dividends?

Bayer pays a quarterly dividend. This is distributed in the months of May, June, June, May.

How secure is the dividend of Bayer?

Bayer paid dividends every year for the past 26 years.

What is the dividend of Bayer?

For the upcoming 12 months, dividends amounting to 2.43 EUR are expected. This corresponds to a dividend yield of 8.86 %.

In which sector is Bayer located?

Bayer is assigned to the 'Health' sector.

Wann musste ich die Aktien von Bayer kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Bayer from 5/2/2024 amounting to 0.11 EUR, you needed to have the stock in your portfolio before the ex-date on 4/29/2024.

When did Bayer pay the last dividend?

The last dividend was paid out on 5/2/2024.

What was the dividend of Bayer in the year 2023?

In the year 2023, Bayer distributed 2 EUR as dividends.

In which currency does Bayer pay out the dividend?

The dividends of Bayer are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Bayer stock can be added to a savings plan with the following providers: Trade Republic, ING, Scalable Capital and Consorsbank

Andere Kennzahlen von Bayer

Our stock analysis for Bayer Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bayer Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.